Literature DB >> 9845365

Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling.

K Zhao1, W Wang, O J Rando, Y Xue, K Swiderek, A Kuo, G R Crabtree.   

Abstract

Lymphocyte activation is accompanied by visible changes in chromatin structure. We find that antigen receptor signaling induces the rapid association of the BAF complex with chromatin. PIP2, which is regulated by activation stimuli, is sufficient in vitro to target the BAF complex to chromatin, but it has no effect on related chromatin remodeling complexes containing SNF2L or hISWI. Purification and peptide sequencing of the subunits of the complex revealed beta-actin as well as a novel actin-related protein, BAF53. beta-actin and BAF53 are required for maximal ATPase activity of BRG1 and are also required with BRG1 for association of the complex with chromatin/matrix. This work indicates that membrane signals control the activity of the mammalian SWI/SNF or BAF complex and demonstrates a direct interface between signaling and chromatin regulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9845365     DOI: 10.1016/s0092-8674(00)81633-5

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  250 in total

Review 1.  Half a century of "the nuclear matrix".

Authors:  T Pederson
Journal:  Mol Biol Cell       Date:  2000-03       Impact factor: 4.138

Review 2.  ATP-dependent chromatin-remodeling complexes.

Authors:  M Vignali; A H Hassan; K E Neely; J L Workman
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  Nuclear actin is associated with a specific subset of hnRNP A/B-type proteins.

Authors:  Piergiorgio Percipalle; Andreas Jonsson; Dmitri Nashchekin; Christina Karlsson; Tomas Bergman; Apostolia Guialis; Bertil Daneholt
Journal:  Nucleic Acids Res       Date:  2002-04-15       Impact factor: 16.971

4.  BAF53 forms distinct nuclear complexes and functions as a critical c-Myc-interacting nuclear cofactor for oncogenic transformation.

Authors:  Jeonghyeon Park; Marcelo A Wood; Michael D Cole
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

5.  Arabidopsis contains ancient classes of differentially expressed actin-related protein genes.

Authors:  Elizabeth Cohen McKinney; Muthugapatti K Kandasamy; Richard B Meagher
Journal:  Plant Physiol       Date:  2002-03       Impact factor: 8.340

6.  Novel functions of the phosphatidylinositol metabolic pathway discovered by a chemical genomics screen with wortmannin.

Authors:  Amani Zewail; Michael W Xie; Yi Xing; Lan Lin; P Fred Zhang; Wei Zou; Jonathan P Saxe; Jing Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-03       Impact factor: 11.205

7.  Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2 alpha.

Authors:  M Nagai; S Tanaka; M Tsuda; S Endo; H Kato; H Sonobe; A Minami; H Hiraga; H Nishihara; H Sawa; K Nagashima
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

8.  Nuclear reprogramming in cell-free extracts.

Authors:  Philippe Collas
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-08-29       Impact factor: 6.237

9.  BRG1-mediated immune tolerance: facilitation of Treg activation and partial independence of chromatin remodelling.

Authors:  Barbara H Chaiyachati; Anant Jani; Yisong Wan; Haichang Huang; Richard Flavell; Tian Chi
Journal:  EMBO J       Date:  2013-01-15       Impact factor: 11.598

10.  Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers.

Authors:  Gregory R Hoffman; Rami Rahal; Frank Buxton; Kay Xiang; Gregory McAllister; Elizabeth Frias; Linda Bagdasarian; Janina Huber; Alicia Lindeman; Dongshu Chen; Rodrigo Romero; Nadire Ramadan; Tanushree Phadke; Kristy Haas; Mariela Jaskelioff; Boris G Wilson; Matthew J Meyer; Veronica Saenz-Vash; Huili Zhai; Vic E Myer; Jeffery A Porter; Nicholas Keen; Margaret E McLaughlin; Craig Mickanin; Charles W M Roberts; Frank Stegmeier; Zainab Jagani
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.